As of March 20, 2020 we are no longer seeing patients in our office due to COVID-19. We are happy to continue caring for you during these uncertain times. We are now offering remote appointments for new and established patients although we will no longer be able to see you in person. For some patients, an in person visit is best, but if you feel that your concern could be addressed online, this may be a convenient option for you.
Basal cell carcinoma (BCC) is the most common form of skin cancer. More than 2 million people are diagnosed with it in the United States each year. BCC is not a life threatening form of skin cancer except in very very rare cases. BCC most commonly happens on the face and may start out looking like a pimple that never goes away.
You are more likely to get BCC if you have the following risk factors:
The only way to diagnose any type of skin cancer is with a skin biopsy. After the BCC is diagnosed, there are several ways to treat a BCC:
Most BCC’s are cured with the prescribed treatment.
Learn more at the American Academy of Dermatology: AAD Basal cell carcinoma.
Our goal here at The Dermatology of Institute of Boston is protect the health of our patients and staff. To continue caring for our patients during these uncertain times, while strictly adhering to the guidelines set by the CDC, we will be only offering virtual consultations. For some patients, an in person visit is best, but if you feel that your concern could be addressed online, this may be a convenient option for you.